0M0F trade ideas
Smart money created and bought the dipRecent analyst downgrade was no less than pure manipulation to create new long term holders, most likely institutional holders as we are approaching the Sep 25th conference. Most analysts are still bullish, and there are several catalysts ahead through 2020 like t:sport, Control-IQ, sales on Basal-IQ, international expansion, and possible UHC coverage. Tandem also seems to have a great management team.
Great long term investmentTandem has turned around. The company recently launched a new insulin pump algorithm and offers the best touch screen pump in the U.S. With international expansion just starting and a new FDA approval in sight next year, its market cap will easily double/triple. Watch out for $70 price level.
CLOSING POSITION - $1.4 MILLION PROFIT Opened a 75,000 share position at $7.22 on 4/26
SOLD today at $26.35 for a $1.4 MILLION DOLLAR PROFIT WITHIN A FEW MONTHS
I will watch the stock..
Years ago this company's old ticker symbol traded as high as $300 under a different company name.
For now, I am out...waiting until earnings...
TNDM will see huge growth - This is a great BUY opportunityTandem just got FDA approval for their t:slim x2 with BASAL-IQ and will be integrating the device with Dexcom G6. Sales will begin as early as August while expansion into several international markets is ongoing. In the meantime, we should expect to see FDA approval for Control-IQ in the first half of 2019. The company will reach cash break even point next year also. Technical chart should soon enter the previous falling wedge and hopefully break through it.
The shorting of TENDEMWe're possibly at the end of wave 5.
Keeping in mind that wave 3 was longer than wave 1, and wave 5 cannot be longer than wave 3.
I think its good opportunity for laddering the sell orders with a stop loss of 11.72 ( the same length as wave 3).
Targets woild be 9.27, 7.9 and 5,83
TNDM Potential Ten Bagger with a homerun productTandem Diabetes Care is a public US medical device manufacturer based in San Diego, CA. The company develops medical technologies for the treatment of diabetes and specifically insulin infusion therapy.
tslim X2 pump will be a huge windfall for this company. Do your own research, personally I'm building a nice position in this one. Currently Breaking out and trading around $3.40, it wont stay cheap long.
www.tandemdiabetes.com
TNDM - Fallen angel breakout Long from $3-3.25 to $4.20 TNDM had a good push today with huge volume. Money flow also had a sharp upward move. We think it will continue its uptrend from here.
* Trade Criteria *
Date First Found- January 8, 2018
Pattern/Why- Fallen angel formation; Breakout trade
Entry Target Criteria- Pull back to $3 or Break of $3.23
Exit Target Criteria- $4.20
Stop Loss Criteria- N/A
Please check back for Trade updates. (Note: Trade update is little delayed here.)
Tandem Diabetes Care Looks Like a Good Daytrade, SwingTrade PlayStock price has not been fully established yet. Lots of uncertainty, meaning lots of opportunity for short term fluctuations. Stock just underwent reverse split. Currently a "low floater", but with real business operations, not just some cheap pump and dump scam from china or some bitcoin stock. Its a real company with real aspirations of survival. Only problem is they have much better established industry peers like Medtronics. They are still considered a player in their respective industry. Keep on watchlist, watch for movement interday, and if opportunity presents, play it.
Reason for watching, low float, recent split, and real company which is a rare thing these days in the stock market it seems like, especially if it has a low float and a real product. No MACD here people, lol. With these risky ones, flat line is a good thing after a big sell off after a reverse split, especially in a bull market. once the sellers are clearly out of the way, that's all you need to know when the stock has a low float, recent reverse split, and healthy trading volume